Moreover, shikonin derivatives dose-dependently regulated the expression of X-linked apoptosis inhibitor (XIAP) in chondrosarcoma cells, leading to damage of mitochondrial membrane potential and subsequent induction of apoptosis. The gene discussed is XIAP; the disease is chondrosarcoma.